Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03090610

Ligand	Ligand name	Chain	PDB	Tanimoto
FOK	FORSKOLIN	A,C	3C16	0.75
FOK	FORSKOLIN	A,C	1CJU	0.75
FOK	FORSKOLIN	A,C	1TL7	0.75
FOK	FORSKOLIN	A,B	1AB8	0.75
FOK	FORSKOLIN	A,C	3C14	0.75
FOK	FORSKOLIN	A,C	1CJT	0.75
FOK	FORSKOLIN	A,B,C	1CUL	0.75
FOK	FORSKOLIN	A,C	1CJV	0.75
FOK	FORSKOLIN	A,C	3C15	0.75
FOK	FORSKOLIN	A,C	1U0H	0.75
FOK	FORSKOLIN	A,B,C	1CS4	0.75
FOK	FORSKOLIN	A,C	1CJK	0.75
SIH	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	H	1DBM	0.79
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.8
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.8
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.8
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.8
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.8
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.71
CO1	17-[3-(3,3-DIMETHYL-OXIRANYL)-1-METHYL-PROPYL]-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-3-OL	A,B	1P8D	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EAU	0.8
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB3	0.8
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB4	0.8
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	2AAX	0.8
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	1H61	0.8
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	3CMF	0.8
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	2Q1V	0.8
HCR	7-HYDROXYCHOLESTEROL	A	1ZHT	0.71
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.74
WIN	methyl (5beta,7alpha,9beta,10alpha,11alpha,12alpha,13beta,15alpha)-15-{[(2E)-3,4-dimethylpent-2-enoyl]oxy}-3,11,12-trihydroxy-2,16-dioxo-13,20-epoxypicras-3-en-21-oate	0,1,2,3,9,A,B,C,F,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	3G71	0.77
20E	(2beta,3beta,5beta,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one	A,D	2R40	0.89
2OB	CHOLESTERYL OLEATE	A	2OBD	0.71
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.79
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.79
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.79
0MA	maslinic acid	A	2QN2	0.72
O1C	2ALPHA-(3-HYDROXYPROPYL)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HB7	0.71
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A	1LHV	0.72
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A,B	3D90	0.72
KH1	5-(2-{1-[1-(4-ETHYL-4-HYDROXY-HEXYLOXY)-ETHYL]-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE}-ETHYLIDENE)-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE8	0.7
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.82
CLL	CHOLESTERYL LINOLEATE	A,B	1CLE	0.71
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	1SQN	0.72
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	2W8Y	0.72
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.87
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.87
PRB	13-ACETYLPHORBOL	A	1PTR	0.71
C3O	2ALPHA-PROPOXY-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAS	0.71
BIV	21-NOR-9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL, 20-(4-HYDROXY-4-METHYLPENTYL)-, (1A,3B,5Z,7E)	A	2HCD	0.7
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.72
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.72
114	COMPACTIN	A,B,C,D	1HW8	0.72
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.77
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.77
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.77
CLR	CHOLESTEROL	A,B	2ZXE	0.72
CLR	CHOLESTEROL	A	1N83	0.72
CLR	CHOLESTEROL	A	2RH1	0.72
CLR	CHOLESTEROL	A	1LRI	0.72
CLR	CHOLESTEROL	A	1ZHY	0.72
CLR	CHOLESTEROL	A	3D4S	0.72
TES	TESTOSTERONE	A	1JTV	0.79
TES	TESTOSTERONE	A	2Q7L	0.79
TES	TESTOSTERONE	A	2Q7I	0.79
TES	TESTOSTERONE	A,B	1J96	0.79
TES	TESTOSTERONE	A	2Q7K	0.79
TES	TESTOSTERONE	A,B	1Q13	0.79
TES	TESTOSTERONE	H	1I9J	0.79
TES	TESTOSTERONE	A,B	1AFS	0.79
TES	TESTOSTERONE	H	1VPO	0.79
TES	TESTOSTERONE	A	2Q7J	0.79
TES	TESTOSTERONE	A,B	3BUR	0.79
TES	TESTOSTERONE	A	2AM9	0.79
B2S	(3alpha,7alpha)-3,7,15-trihydroxy-12,13-epoxytrichothec-9-en-8-one	A	3B2S	0.72
DEX	DEXAMETHASONE	A,D	1M2Z	0.84
DEX	DEXAMETHASONE	A,B,C,D	1P93	0.84
C0R	CORTICOSTERONE	A	2A3I	0.84
C0R	CORTICOSTERONE	A,B	1Y5R	0.84
MOU		A,B	2NPF	0.71
OCC	2ALPHA-(3-HYDROXYPROPOXY)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAR	0.71
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	A,D	1R1K	0.89
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,U	1Z5X	0.89
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,F,G,H	2NXX	0.89
VD2	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYL-CYCLOHEXANE-1,3-DIOL	A	1RKH	0.71
GR4		H,I	1AWF	0.79
AS4	ALDOSTERONE	A	2AA2	0.82
AS4	ALDOSTERONE	A	2Q1H	0.82
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.74
OVA	3,4-DIHYDROXY-2-METHOXY-4-METHYL-3-[2-METHYL-3-(3-METHYL-BUT-2-ENYL) -OXIRANYL]-CYCLOHEXANONE	A	2GZ5	0.76
OVA	3,4-DIHYDROXY-2-METHOXY-4-METHYL-3-[2-METHYL-3-(3-METHYL-BUT-2-ENYL) -OXIRANYL]-CYCLOHEXANONE	A	1B59	0.76
13T	13-DEOXYTEDANOLIDE	0,1,3,9,A,B,C,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	2OTJ	0.7
0AS	asiatic acid	A	2QN1	0.76
ZK5	9ALPHA-FLUOROCORTISOL	A	1GS4	0.85
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.8
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.8
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.8
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.8
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.8
803	LOVASTATIN	A,B	1CQP	0.71
HC3	25-HYDROXYCHOLESTEROL	A	1ZHX	0.74
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.76
GA4	GIBBERELLIN A4	A	2ZSI	0.71
GA4	GIBBERELLIN A4	A,B,C,D,E,F	3EBL	0.71
GA4	GIBBERELLIN A4	H,I	1KFA	0.71
HC2	20-HYDROXYCHOLESTEROL	A	1ZHW	0.74